Skip to content

Clinical trials

Completed Congenital Abnormalities trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Status: Completed Country / region: France Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20054
20061
20071
20081
20092
20124
20142
20151
20162
20172
20183
20194
20201
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Institut Paoli-Calmettes4
Assistance Publique - Hôpitaux de Paris3
Hospices Civils de Lyon3
Institut National de la Santé Et de la Recherche Médicale, France2
Vion Pharmaceuticals2
Aesthetic Group1
Assistance Publique Hopitaux De Marseille1
Centre Hospitalier Universitaire Dijon1
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities35
Leukemia8
Leukemia, Myeloid, Acute8
Leukemia, Monocytic, Acute4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative4
Leukemia, Myelomonocytic, Acute4
Leukemia, Myelomonocytic, Chronic4
Myeloproliferative Disorders4
Blast Crisis3
Burkitt Lymphoma3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.